These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31451563)

  • 1. Microvesicle-Mediated Delivery of Minicircle DNA Results in Effective Gene-Directed Enzyme Prodrug Cancer Therapy.
    Kanada M; Kim BD; Hardy JW; Ronald JA; Bachmann MH; Bernard MP; Perez GI; Zarea AA; Ge TJ; Withrow A; Ibrahim SA; Toomajian V; Gambhir SS; Paulmurugan R; Contag CH
    Mol Cancer Ther; 2019 Dec; 18(12):2331-2342. PubMed ID: 31451563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SP94-Targeted Triblock Copolymer Nanoparticle Delivers Thymidine Kinase-p53-Nitroreductase Triple Therapeutic Gene and Restores Anticancer Function against Hepatocellular Carcinoma in Vivo.
    Sukumar UK; Rajendran JCB; Gambhir SS; Massoud TF; Paulmurugan R
    ACS Appl Mater Interfaces; 2020 Mar; 12(10):11307-11319. PubMed ID: 32048820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging.
    Sekar TV; Foygel K; Willmann JK; Paulmurugan R
    Gene Ther; 2013 May; 20(5):529-37. PubMed ID: 22914496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy.
    Devulapally R; Lee T; Barghava-Shah A; Sekar TV; Foygel K; Bachawal SV; Willmann JK; Paulmurugan R
    Nanomedicine (Lond); 2018 May; 13(9):1051-1066. PubMed ID: 29790803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive optical imaging of nitroreductase gene-directed enzyme prodrug therapy system in living animals.
    Bhaumik S; Sekar TV; Depuy J; Klimash J; Paulmurugan R
    Gene Ther; 2012 Mar; 19(3):295-302. PubMed ID: 21753794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of enzyme prodrug gene therapy combinations in coated spheroids and vascular networks in vitro.
    Hunt MA; Li D; Hay MP; Currie MJ; Robinson BA; Patterson AV; Dachs GU
    J Gene Med; 2012 Jan; 14(1):62-74. PubMed ID: 22147660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite.
    Bridgewater JA; Knox RJ; Pitts JD; Collins MK; Springer CJ
    Hum Gene Ther; 1997 Apr; 8(6):709-17. PubMed ID: 9113510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of herpes simplex virus thymidine kinase and Escherichia coli nitroreductase by an hTERT-driven adenovirus vector in breast cancer cells results in additive anti-tumor effects.
    Yu B; Zhang Y; Zhan Y; Zha X; Wu Y; Zhang X; Dong Q; Kong W; Yu X
    Oncol Rep; 2011 Jul; 26(1):255-64. PubMed ID: 21573500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-directed enzyme prodrug therapy using CB1954.
    Grove JI; Searle PF; Weedon SJ; Green NK; McNeish IA; Kerr DJ
    Anticancer Drug Des; 1999 Dec; 14(6):461-72. PubMed ID: 10834268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in imaging gene-directed enzyme prodrug therapy.
    Bhaumik S
    Curr Pharm Biotechnol; 2011 Apr; 12(4):497-507. PubMed ID: 21342105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
    Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA
    J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo.
    Uckert W; Kammertöns T; Haack K; Qin Z; Gebert J; Schendel DJ; Blankenstein T
    Hum Gene Ther; 1998 Apr; 9(6):855-65. PubMed ID: 9581908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrugs in genetic chemoradiotherapy.
    Patterson AV; Saunders MP; Greco O
    Curr Pharm Des; 2003; 9(26):2131-54. PubMed ID: 14529410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954.
    Bridgewater JA; Springer CJ; Knox RJ; Minton NP; Michael NP; Collins MK
    Eur J Cancer; 1995 Dec; 31A(13-14):2362-70. PubMed ID: 8652270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy.
    Chan-Hyams JVE; Copp JN; Smaill JB; Patterson AV; Ackerley DF
    Biochem Pharmacol; 2018 Dec; 158():192-200. PubMed ID: 30352235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancer.
    Kalimuthu S; Oh JM; Gangadaran P; Zhu L; Lee HW; Jeon YH; Jeong SY; Lee SW; Lee J; Ahn BC
    PLoS One; 2017; 12(7):e0181318. PubMed ID: 28727740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures.
    Wilson WR; Pullen SM; Hogg A; Helsby NA; Hicks KO; Denny WA
    Cancer Res; 2002 Mar; 62(5):1425-32. PubMed ID: 11888915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954.
    McNeish IA; Green NK; Gilligan MG; Ford MJ; Mautner V; Young LS; Kerr DJ; Searle PF
    Gene Ther; 1998 Aug; 5(8):1061-9. PubMed ID: 10326029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated enzyme prodrug cancer therapies.
    Mooney R; Abdul Majid A; Batalla J; Annala AJ; Aboody KS
    Adv Drug Deliv Rev; 2017 Sep; 118():35-51. PubMed ID: 28916493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.